Jeffrey Lacey

Secretary & Treasurer at NextPoint Therapeutics.

Raised on NextPoint Therapeutics filings

$33.7M

of $48.7M offered across 1 Form D filing

Company

Biotech · Cambridge, MA

Antibodies against the B7-H7 checkpoint in cancer

Antibodies against the B7-H7 checkpoint in cancer

NextPoint Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jul 30, 2026	Equity	$33.7M/ $48.7M	Form D